SMTL ID : 5kvt.1

THE STRUCTURE OF TRKA KINASE DOMAIN BOUND TO THE INHIBITOR ENTRECTINIB

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x YMX: Entrectinib(Non-covalent)

YMX.1: 20 residues within 4Å: Chain A: L.16, G.17, E.18, F.21, V.24, A.42, F.89, E.90, Y.91, M.92, R.93, G.95, D.96, R.99, R.154, N.155, C.156, L.157, G.167, D.168 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.16, A:F.21, A:F.89, A:D.96, A:L.157, A:D.168 Hydrogen bonds: A:E.90, A:M.92, A:M.92

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 7 residues within 4Å: Chain A: W.211, W.228, I.240, R.244, E.245, L.246, W.264 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:L.246 Water bridges: A:W.211

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Drilon, A., Antitumor Activity and Safety of the Pan-TRK, ROS1, and ALK inhibitor Entrectinib (RXDX-101): Combined Results from Two Phase I Trials. To Be Published

Release Date

2017-12-27

Peptides

High affinity nerve growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

High affinity nerve growth factor receptor